Citius Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -52 | -52 | -51 | |
EBITDA | -10,996 | -10,581 | -10,969 | -9,340 |
EBIT | -11,050 | -10,634 | -11,021 | -9,391 |
Net Income | -10,790 | -10,573 | -8,544 | -9,231 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,912 | -8,367 | -7,786 | -6,135 |
Cash | 3,251 | 17,911 | 12,559 | 20,345 |
Basic Shares | 173,856 | 173,856 | 159,072 | 158,955 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -194 | -179 | -164 | |
EBITDA | -36,729 | -32,884 | -22,878 | |
EBIT | -36,923 | -33,064 | -23,043 | |
Net Income | -39,425 | -32,542 | -33,640 | -23,125 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -28,361 | 56,213 | ||
Free Cash Flow | -28,201 | -29,060 | -28,361 | -64,257 |
Cash | 3,251 | 26,480 | 41,711 | 70,072 |
Basic Shares | 173,856 | 151,294 | 146,082 | 108,599 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.58 |
2024-06-30 | -$0.06 |
2024-03-31 | -$0.05 |
2023-12-31 | -$0.06 |
